1. Histamine H3 receptor antagonists with peptidomimetic (keto)piperazine structures to inhibit Aβ oligomerisation. (15th November 2021) Authors: Falkenstein, Markus; Reiner-Link, David; Zivkovic, Aleksandra; Gering, Ian; Willbold, Dieter; Stark, Holger Journal: Bioorganic & medicinal chemistry Issue: Volume 50(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Multitargeting approaches to cognitive impairment: Synthesis of aryl-alkylpiperazines and assessment at cholinesterases, histamine H3 and dopamine D3 receptors. (15th January 2023) Authors: Aranha, Cecília M.S.Q.; Reiner-Link, David; Leitzbach, Luisa R.; Lopes, Flavia B.; Stark, Holger; Fernandes, João Paulo S. Journal: Bioorganic & medicinal chemistry Issue: Volume 78(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease. (31st December 2023) Authors: Hafez, Donia E.; Dubiel, Mariam; La Spada, Gabriella; Catto, Marco; Reiner-Link, David; Syu, Yu-Ting; Abdel-Halim, Mohammad; Hwang, Tsong-Long; Stark, Holger; Abadi, Ashraf H. Journal: Journal of enzyme inhibition and medicinal chemistry Issue: Volume 38:Number 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OLHA (Nα-oleoylhistamine) modulates activity of mouse brain histaminergic neurons. (1st September 2022) Authors: Sergeeva, Olga A.; Mazur, Karolina; Reiner-Link, David; Lutsenko, Kiril; Haas, Helmut L.; Alfonso-Prieto, Mercedes; Stark, Holger Journal: Neuropharmacology Issue: Volume 215(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗